Zobrazeno 1 - 10
of 36
pro vyhledávání: '"David H Brown Ripin"'
Autor:
David H Brown Ripin, Kelly Catlin, Linda Lewis, Danielle Resar, Carolyn Amole, Robert C Bollinger, Charles Flexner
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 75(Supplement_4)
Development of and increased access to generic oral medications to treat high-burden diseases including human immunodeficiency virus (HIV), tuberculosis, viral hepatitis, and malaria have had a major impact on reducing global morbidity and mortality.
Publikováno v:
Practical Synthetic Organic Chemistry. :513-562
Autor:
David H. Brown Ripin, Adam R. Brown
Publikováno v:
Practical Synthetic Organic Chemistry
Autor:
David H. Brown Ripin, Chad A. Lewis
Publikováno v:
Practical Synthetic Organic Chemistry. :377-423
Autor:
Michelle Moorhouse, Sarah Stacey, Godspower Akpomiemie, Ellisha Maharaj, David H Brown Ripin, Ambar Qavi, Joel W Sim, Phumla Sinxadi, Simiso Sokhela, Lubbe Wiesner, Celicia Serenata, Nonkululeko Mashabane, Willem D F Venter, Gila Chitauri, Tom H. Boyles, Natasha Arulappan, Andrew Hill, Carole L. Wallis
Publikováno v:
The Lancet HIV. 6:e428-e437
Pilot studies suggest that ritonavir-boosted darunavir could show high efficacy at doses below those currently approved. We investigated whether switch to 400 mg of darunavir boosted with 100 mg ritonavir once daily could show equivalent efficacy to
Autor:
Willem Daniel Francois, Venter, Andrew, Kambugu, Matthew F, Chersich, Stephen, Becker, Andrew, Hill, Natasha, Arulappan, Michelle, Moorhouse, Mohammed, Majam, Godspower, Akpomiemie, Simiso, Sokhela, Selvamuthu, Poongulali, Charles, Feldman, Chris, Duncombe, David H Brown, Ripin, Alinda, Vos, Nagalingeswaran, Kumarasamy
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes (1999)
Supplemental Digital Content is Available in the Text.
Background: Reducing doses of antiretroviral drugs, including stavudine (d4T), may lower toxicity, while preserving efficacy. There are substantial concerns about renal and bone toxicities o
Background: Reducing doses of antiretroviral drugs, including stavudine (d4T), may lower toxicity, while preserving efficacy. There are substantial concerns about renal and bone toxicities o
Publikováno v:
Green Techniques for Organic Synthesis and Medicinal Chemistry
Autor:
Joseph M. Fortunak, David H. Brown Ripin, Jack Melton, Stephen R. Houghton, Christopher N. Boddy
Publikováno v:
Tetrahedron. 66:8137-8144
A rapid, low temperature hydrolysis of tenofovir diethyl ester mediated by TMSCl and NaBr was identified and demonstrated to be superior to the current production method, TMSBr-mediated hydrolysis. This mild phosphonate ester hydrolysis was then coup
Autor:
Christopher N. Boddy, Frajovon Talley, Stephen R. Houghton, L. Nagaprasada Rao, Jack Melton, Shaik Muneer, Nylea Bivins, Gottumukkala V. Subbaraju, David S. Teager, Adrian Williams, Tricia Silverton, Stephen R. Byrn, Nardla Gopal Reddy, K. Chandra Shekar, Daniel T. Smith, S. Tirumala Jagadeesh, David H. Brown Ripin, R. Venkateswara Rao, Puma Chandra Ray, Kelly K. Catlin, Rodger W. Stringham, Joseph M. Fortunak, Shaik Mahaboob Basha, Ravi Mallikarjuna Reddy, K. Anesh Kumar
Publikováno v:
Organic Process Research & Development. 14:1194-1201
The three-step manufacturing process used in the synthesis of tenofovir disoproxil fumarate (1) was studied and optimized, leading to a more productive and robust process. The yield was improved from about 13% overall to 24%. Key process improvements
Autor:
and Clifford N. Meltz, Pamela J. Clifford, David R. Bill, Gerald A. Weisenburger, James E. Phillips, David H. Brown Ripin, David J. am Ende
Publikováno v:
Organic Process Research & Development. 11:762-765
In order to run a peracid oxidation on multikilogram scale in a pilot plant facility with an acceptable level of risk, an extensive study of the thermal characteristics of the reaction, reactants, and quench was undertaken. A number of features were